A new trading day began on Tuesday, with Ovid Therapeutics Inc (NASDAQ: OVID) stock price down -3.91% from the previous day of trading, before settling in for the closing price of $1.28. OVID’s price has ranged from $0.24 to $1.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 24.72% over the last five years. Meanwhile, its annual earnings per share averaged -35.91%. With a float of $59.50 million, this company’s outstanding shares have now reached $71.11 million.
Ovid Therapeutics Inc (OVID) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ovid Therapeutics Inc is 16.33%, while institutional ownership is 34.63%. The most recent insider transaction that took place on Feb 26 ’25, was worth 2,956. In this transaction President and COO of this company sold 5,279 shares at a rate of $0.56, taking the stock ownership to the 73,406 shares. Before that another transaction happened on Feb 26 ’25, when Company’s CBFO sold 3,902 for $0.56, making the entire transaction worth $2,185. This insider now owns 67,973 shares in total.
Ovid Therapeutics Inc (OVID) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.2 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
Here are Ovid Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Ovid Therapeutics Inc (OVID)
Analysing the last 5-days average volume posted by the [Ovid Therapeutics Inc, OVID], we can find that recorded value of 1.91 million was better than the volume posted last year of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 92.14%.
During the past 100 days, Ovid Therapeutics Inc’s (OVID) raw stochastic average was set at 93.70%, which indicates a significant increase from 91.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1283 in the past 14 days, which was higher than the 0.0502 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6292, while its 200-day Moving Average is $0.6068. Now, the first resistance to watch is $1.2767. This is followed by the second major resistance level at $1.3233. The third major resistance level sits at $1.3667. If the price goes on to break the first support level at $1.1867, it is likely to go to the next support level at $1.1433. Should the price break the second support level, the third support level stands at $1.0967.
Ovid Therapeutics Inc (NASDAQ: OVID) Key Stats
With a market capitalization of 87.46 million, the company has a total of 71,110K Shares Outstanding. Currently, annual sales are 570 K while annual income is -26,430 K. The company’s previous quarter sales were 6,270 K while its latest quarter income was -4,680 K.
